Related Experiment Video

Updated: Jun 13, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular

Qamar Abuhassan1, Kamel Saleh2, S Renuka Jyothi3

  • 1Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Jordan, Amman, 11942, Jordan.

Bioimpacts : BI
|June 12, 2026
PubMed

Insights

New strategies are needed for ocular cancers due to limited success with current immunotherapies. This review explores multidimensional immune engineering, combining advanced technologies to reconfigure the tumor microenvironment for vision-preserving treatments.

Area of Science:

  • Ophthalmology
  • Immunology
  • Oncology
  • Biotechnology
  • Artificial Intelligence

Background:

  • Ocular malignancies, like uveal and conjunctival melanoma, grow in the immune-privileged eye microenvironment.
  • Current immunotherapies (e.g., PD-1/PD-L1, CTLA-4 blockade) show limited efficacy against these tumors.
  • There's a critical need for advanced, multidimensional immune engineering approaches.

Purpose of the Study:

  • To reframe ocular immunotherapy by integrating synthetic bio-nanotechnology, AI-guided immunogenomics, and spatial immunomics.
  • To redefine programmatic regulation of tolerance and immunity within ocular tissues.
  • To outline a roadmap for vision-preserving immunotherapy in ocular oncology.

Main Methods:

  • Synthesizing recent advances in bispecific T-cell engagers, oncolytic viro-immunotherapy, mRNA and dendritic-cell vaccines, and engineered CAR/TCR-T platforms.
  • Exploring novel concepts like logic-gated antibodies, ROS-responsive nanocarriers, and CRISPR-assisted checkpoint reprogramming for precision immune engineering.
  • Proposing a systems-level model for ocular immuno-oncology 2.0, viewing immune privilege as a configurable therapeutic circuit.

Main Results:

  • These advanced platforms can reconfigure the ocular tumor microenvironment from immune-silent to immune-responsive.
  • Developments aim to temporarily modulate immune privilege without compromising visual quality.
  • Integration of AI-driven neoantigen detection, liquid-biopsy feedback, and flexible biomaterials offers potential for long-lasting, vision-preserving treatments.

Conclusions:

  • Ocular immune privilege can be dynamically regulated for therapeutic orchestration.
  • A systems-level approach to ocular immuno-oncology is emerging.
  • While many strategies are in early stages, they present a plausible path toward effective, vision-preserving immunotherapies for ocular cancers.
Keywords:
AI-guided personalized immunotherapyCheckpoint inhibition resistanceImmune-privileged tumor microenvironmentNanocarrier-based immune modulationNeoantigen-driven immunotherapyOcular immuno-oncology

More Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research08:17

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on: August 15, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...